BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Clinical trial NCT03482635 · COMPLETED
Trial details
- NCT number
- NCT03482635
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2020-05-18
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.